Pharmaniaga Promethazine

Quick links

Choose a section

Quick links to important sections

Advertisements

Pharmaniaga Promethazine

Advertisements
Advertisements

Overview of Pharmaniaga Promethazine

Quick Facts

Property Description
Active ingredient Promethazine hydrochloride
Form Tablets, Syrup, Solution for Injection
Pharmacological class First-generation Antihistamine
Common use Allergy relief, anti-nausea, sedation
Origin Synthetic (Phenothiazine derivative)

What Type of Medicine is Promethazine? (Class, Composition, and Origin)

Pharmaniaga Promethazine is a pharmaceutical preparation containing the synthetic active ingredient Promethazine hydrochloride. The drug is formally classified as a first-generation antihistamine and a member of the phenothiazine derivative chemical group. This classification establishes its profile as an agent that blocks the effects of histamine and significantly influences the central nervous system.

Promethazine is defined by this potent antihistaminic action combined with a marked sedating effect. This distinguishes its pharmacological behavior from newer, non-drowsy antihistamines.

What are the Available Forms of Promethazine? (Format and Preparation)

The medication is supplied as a single active ingredient preparation in several key forms for different clinical needs. These include solid oral tablets, a liquid syrup for oral ingestion, and a sterile solution for injection intended for rapid administration in medical settings. The preparation uses Promethazine hydrochloride dissolved in an appropriate aqueous or non-aqueous base, depending on the final form.

What is the General Purpose of Promethazine? (High-Level Benefit)

Promethazine is utilized for its capacity to address symptoms arising from histamine release, offering relief from common signs of allergy. Beyond its anti-allergic function, the drug is clinically recognized as an effective antiemetic (anti-nausea) agent. It has an established utility in the prevention and treatment of nausea and vomiting, particularly when related to motion sickness. Furthermore, the inherent sedative property of Promethazine means it is applied to assist with short-term rest or to promote a state of calm when medically indicated.

Regulatory References

  1. first-generation antihistamine
  2. syrup
  3. solution for injection
  4. NIH StatPearls
  5. National Library of Medicine (MedlinePlus)
Advertisements

What side effects are possible with Pharmaniaga Promethazine?

Possible Side Effects and Safety Information

Official regulatory documents organize the safety profile of Promethazine into frequency classifications and affected organ systems. The most common and expected adverse reaction is sedation or somnolence, which is classified as Very Common in regulatory documents [Source: FDA Label]. Many other documented effects are classified with a Frequency Not Known (cannot be estimated from available data).


System-Organ Classes and Documented Reactions

Adverse reactions span multiple System-Organ Classes (SOCs) as listed in regulatory labeling.

System-Organ Class Documented Examples
Nervous System Dizziness, Headache, Confusion, Extrapyramidal Symptoms
Gastrointestinal Dry Mouth (Xerostomia), Constipation
Skin/Immune Photosensitivity, Urticaria, Rash
Cardiac/Vascular Hypotension (low blood pressure), Arrhythmias

Serious Safety Considerations

The official labeling highlights several serious safety risks. Promethazine carries a documented risk of fatal respiratory depression, which is the basis for a strict contraindication for use in children under 2 years of age [Source: FDA Label (Boxed Warning)]. Other rare but serious documented risks include the potential for Neuroleptic Malignant Syndrome (NMS) and severe Blood Dyscrasias (e.g., Agranulocytosis). The medicine is also noted to lower the seizure threshold.

Time and Population-Specific Notes

The sedative effects may diminish after a few days of continuous use. Older adults may experience increased susceptibility to side effects, including severe drowsiness and confusion. Extrapyramidal symptoms may appear within the first few days of treatment or following dose increases [Source: SmPC Equivalents].

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage of Promethazine is officially documented to present with signs of severe central nervous system (CNS) toxicity, which can manifest in two contrasting ways. Symptoms of CNS depression include profound drowsiness, listlessness, or progressing to unconsciousness and deep coma. Conversely, paradoxical excitation may occur, characterized by agitation, confusion, hallucinations, and generalized seizures (convulsions). Anticholinergic signs, such as a rapid heart rate (tachycardia), dilated pupils, dry mouth, and urinary retention, are also consistent with overdosage.

Serious and Life-Threatening Outcomes The official labeling states that overdosage carries the risk of potentially fatal respiratory depression (slowed or stopped breathing) and severe cardiac rhythm irregularities (arrhythmias). Sudden death has been reported in pediatric patients with excessively large dosages. Children are particularly susceptible to CNS excitation and critical respiratory effects.

Mandatory Emergency Actions Regulatory authorities require individuals to seek immediate medical attention for any suspected overdosage. Contact emergency services (e.g., 911) or the Poison Help hotline immediately if the person collapses, experiences a seizure, has trouble breathing, or cannot be awakened. The management of overdose is symptomatic and supportive, as no specific antidote is known. The official guidance contains a critical warning that Epinephrine must not be used to treat low blood pressure associated with Promethazine overdosage.

Advertisements

Therapeutic Uses of Pharmaniaga Promethazine

What Pharmaniaga Promethazine Treats: Main Uses and Benefits

The therapeutic relevance of Pharmaniaga Promethazine involves its application in managing symptoms that interfere with daily functioning and become disruptive during flare-ups. The medication is used across domains where symptomatic support is needed, primarily assisting with allergic reactions, the management of nausea and vomiting, and providing supportive sedation. Specifically, it helps address symptom clusters that may become intense, including sneezing, itching, sickness, dizziness, and apprehension.

“It is commonly used across conditions presenting with acute episodes, where managing symptom intensity is key to patient comfort.”

Quick Fact: Symptom Management Domains

Therapeutic Focus Symptoms Addressed (Examples) Common Contexts of Use
Allergy Symptoms Itching, sneezing, runny nose, ocular irritation Seasonal or perennial allergic episodes
Sickness Management Nausea, vomiting, motion sickness Travel or post-operative recovery
Supportive Rest Apprehension, restlessness, difficulty resting Pre-procedural comfort and support

This use provides support that helps ease the overall symptom burden, contributing to improved comfort during symptomatic periods, and assisting with maintaining functional stability during difficult episodes.

Regulatory References

  1. Promethazine: MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Promethazine is a prescription medication used for conditions such as allergies, motion sickness, and to aid sleep or sedation. Its use is determined by a patient’s specific medical profile and age.

Who Can Typically Use Promethazine

Promethazine is generally considered safe and effective for adults and children aged two years and older when prescribed by a healthcare professional for approved indications. Dosage will vary based on the patient's age, weight, and the condition being treated.


Who Should Not Use Promethazine

There are several contraindications where Promethazine should be avoided due to the risk of serious adverse effects. Absolute contraindications include:

  • Children under two years of age due to the potentially fatal risk of respiratory depression.
  • Patients who are comatose or have a history of hypersensitivity or allergic reaction to promethazine or other phenothiazines.
  • Use with certain other medications, particularly monoamine oxidase inhibitors (MAOIs), is typically avoided.

Caution is required in patients with conditions such as:**

  • Glaucoma or prostatic hypertrophy (due to its anticholinergic effects).
  • Cardiovascular disease.
  • Epilepsy or other seizure disorders.
  • Asthma or other respiratory impairment (due to the risk of exacerbating symptoms).
Advertisements

What should I know about interactions with other medicines?

Promethazine can interact with several medicinal products and substance categories, primarily by potentiating or intensifying their effects.

Key Interacting Classes and Substances

Category Interaction Mechanism/Effect Restriction/Classification
CNS Depressants (e.g., alcohol, opioids, hypnotics, sedatives, tricyclic antidepressants, tranquilizers, general anesthetics, some other antihistamines) Additive or potentiated CNS depression, leading to increased drowsiness, sedation, or respiratory depression. Avoid alcohol. Reduce dosage or eliminate other CNS depressants.
Monoamine Oxidase Inhibitors (MAOIs) Intensification of anticholinergic and CNS depressant effects, increasing the risk of hypotension and extrapyramidal reactions. Avoid promethazine use in patients taking MAOIs up to 14 days previously.
Anticholinergic Agents (e.g., atropine, some antidepressants) Additive antimuscarinic effects, increasing the risk of side effects like dry mouth, blurred vision, and urinary retention. Use with caution; dosage adjustment may be needed.

Other Important Interactions

Promethazine may block the alpha-adrenergic effects of adrenaline (epinephrine), which can result in severe hypotension and tachycardia; therefore, adrenaline is contraindicated for pressor support in promethazine-treated patients. The drug's anti-emetic action can mask signs of ototoxicity caused by other medications, such as salicylates, or mask symptoms of an acute surgical condition. Promethazine may lower the seizure threshold, requiring adjustment of anticonvulsant dosage. It may also interfere with immunological urine pregnancy tests and requires discontinuation at least 72 hours before allergen skin testing due to its effect on the cutaneous histamine response.

Advertisements

Mechanism of Action

The drug's primary action involves its binding as an antagonist at the Histamine H1 receptors in both peripheral tissues and within the central nervous system (CNS) . By competitively blocking these receptors, the drug suppresses histamine-mediated signaling, which is crucial for maintaining wakefulness and arousal. This interference within the histaminergic pathway leads directly to CNS depression. A secondary action involves antagonizing receptors in other key neural pathways, specifically Dopamine D2 and muscarinic cholinergic receptors. This multi-target engagement is concentrated in brain regions controlling balance and the vomiting reflex (the Chemoreceptor Trigger Zone or CTZ). This mechanism modifies the early molecular steps that relay signals from the inner ear and gut, resulting in signal modulation within the vestibular system and the downstream modulation of the relay of excessive signaling on the brain's control centers.

Advertisements

Dosage and Administration Information

How Pharmaniaga Promethazine is Used: Administration Guidelines

Promethazine is administered using specific methods to ensure correct use. The medication is available in several forms and may be administered via approved routes including oral (tablets, syrup), rectal (suppositories), and parenteral (deep intramuscular or, with strict caution, intravenous injection).


Dosing and Frequency (Adults)

Dosing for adults typically starts in the range of 12.5 mg to 25 mg, adjusted to the smallest effective dose required. The medication may be taken as a single daily dose, often at bedtime, or in divided doses every 4 to 6 hours as needed (PRN), depending on the specific use.

Administration Pattern Typical Adult Dose Range Frequency Guideline
Oral 12.5 mg to 25 mg Once daily, or 4-6 hours PRN
Parenteral (IM/IV) 12.5 mg to 25 mg initial dose Repeat every 4-6 hours, maximum 100 mg/day

Key Administration Rules and Constraints

Specific rules govern how the medicine is to be prepared and given:

  • Oral Intake: Tablets and syrup may be taken with or without food or milk to help minimize potential gastric irritation.
  • Parenteral Use: Deep intramuscular (IM) injection is the preferred route for injection. Intravenous (IV) administration requires mandatory dilution of the solution and must not exceed a slow infusion rate of 25 mg/minute into a large vein.
  • Age Restriction: Promethazine is contraindicated for use in pediatric patients less than 2 years of age and should be used cautiously in children 2 years and older at the lowest effective dose.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Pharmaniaga Promethazine

Evidence for Use in Symptomatic Allergic Conditions

Research examining Pharmaniaga Promethazine for conditions characterized by fluctuating or episodic allergic manifestations relies largely on historical regulatory evidence and older clinical trials. Studies explored how symptoms such as itching, sneezing, and ocular irritation evolved during the study period in adult populations and children aged 2 years and older. Findings described patterns related to changes in patient-reported outcomes linked to inflammatory or irritative states. Studies also monitored objective physiological reactions, such as the skin’s response to histamine, as part of the broader evidence landscape for this class of medication.

Comparative evidence involving Promethazine and other contemporary antihistamine medicines is lacking in recent scientific literature. Consequently, limited information exists regarding the long-term outcomes associated with managing chronic or perennial allergic conditions.

Evidence for Use in Preventing and Controlling Nausea and Vomiting

Research examined Promethazine in studies focusing on episodes where symptoms become more noticeable, particularly in conditions associated with acute or disruptive episodes like motion sickness or post-operative recovery. Studies were evaluated to understand outcomes related to systemic or functional imbalance. Researchers monitored the frequency of vomiting and patient-reported outcomes describing perceived discomfort to assess changes during the study period.

Comparative evidence is available from some studies, reporting mixed findings when measured against other active control agents. While the research highlights what is known about changes in symptoms in acute situations, follow-up durations were often limited to the short-term.

Evidence for Use as Short-term Supportive Sedation

Research explored temporary states of restlessness or apprehension, particularly in pre-procedural contexts. Studies monitored changes in patient-reported experiences related to apprehension and described patterns observed in the ability to achieve short-term rest. Sedation was observed in studies, although research outcomes often measured this effect secondary to anti-nausea or procedural pain protocols. Certainty remains low regarding its specific use as a primary agent for supportive rest outside of these procedural settings, as dedicated trials focusing on supportive sleep outcomes are not fully established.

What is Still Uncertain About the Research Landscape

The evidence highlights what is known, but also where certainty remains low or where research is needed. Comparative evidence is lacking for several indications. Follow-up durations were limited across much of the study landscape; consequently, long-term effects are not fully established. Additionally, findings were mixed in some comparative trials for anti-nausea use. Finally, evidence quality varies across studies, and data for certain subgroups requiring long-term care or with complex conditions are still emerging; therefore, results apply primarily to the short-term populations studied.

Key Studies & References

  1. Promethazine Drug Information - MedlinePlus
  2. Promethazine. StatPearls [Internet]
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Pharmaniaga Promethazine (FAQ)

Q: What is Promethazine primarily used for?

A: Promethazine is an antihistamine that may be used for several purposes, including managing symptoms of certain allergic reactions, preventing and controlling nausea and vomiting, and aiding in sleep as a short-term aid.

Q: How should I take Promethazine safely?

A: The proper way to take this medication depends on the specific product and indication determined by a healthcare provider. It is important to follow the directions given on the prescription label or by your doctor exactly. Always consult a healthcare professional for specific guidance on administration.

Q: Does Promethazine cause drowsiness?

A: Yes, drowsiness is a commonly reported side effect associated with the use of promethazine. Individuals who experience this effect should be cautious when performing tasks that require mental alertness, such as operating heavy machinery or driving.

Q: Can I drink alcohol while taking Promethazine?

A: Combining alcohol with promethazine may significantly increase the depressant effects on the central nervous system, which can lead to increased drowsiness, dizziness, and impaired judgment. It is generally advised to avoid consuming alcohol while using this medication.

Q: What should I do if I miss a dose?

A: If a dose is missed, it is generally advised to take it as soon as you remember, unless it is nearly time for your next scheduled dose. In that case, you should skip the missed dose and return to your regular dosing schedule. Do not take two doses at the same time to make up for a missed dose. Always seek advice from your healthcare provider for specific directions regarding missed doses.

Advertisements

How should Pharmaniaga Promethazine be stored and disposed of?

Storage Requirements

Promethazine must be stored at a Controlled Room Temperature, typically 20 to 25C (68 to 77F), with allowed variations up to 30C. The medication requires protection from light and must be kept in a tight, light-resistant container, such as the original bottle. The injection solution is explicitly prohibited from being frozen to maintain stability.

Child Safety and Disposal

All forms of Promethazine must be stored with a child-resistant closure and kept out of the sight and reach of children.

For disposal, regulatory instructions state that unused or expired product should not be placed in household waste or flushed down the toilet. Individuals are advised to consult a pharmacist or local authority regarding proper pharmaceutical waste disposal procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pharmaniaga Promethazine found in:

A-Z Index: